334 related articles for article (PubMed ID: 27294523)
1. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
[TBL] [Abstract][Full Text] [Related]
2. Jagged1 upregulation in prostate epithelial cells promotes formation of reactive stroma in the Pten null mouse model for prostate cancer.
Su Q; Zhang B; Zhang L; Dang T; Rowley D; Ittmann M; Xin L
Oncogene; 2017 Feb; 36(5):618-627. PubMed ID: 27345403
[TBL] [Abstract][Full Text] [Related]
3. Amino-terminal enhancer of split gene AES encodes a tumor and metastasis suppressor of prostate cancer.
Okada Y; Sonoshita M; Kakizaki F; Aoyama N; Itatani Y; Uegaki M; Sakamoto H; Kobayashi T; Inoue T; Kamba T; Suzuki A; Ogawa O; Taketo MM
Cancer Sci; 2017 Apr; 108(4):744-752. PubMed ID: 28178391
[TBL] [Abstract][Full Text] [Related]
4. NOTCH and PTEN in prostate cancer.
Bertrand FE; McCubrey JA; Angus CW; Nutter JM; Sigounas G
Adv Biol Regul; 2014 Sep; 56():51-65. PubMed ID: 24933481
[TBL] [Abstract][Full Text] [Related]
5. Notch-1 signaling is lost in prostate adenocarcinoma and promotes PTEN gene expression.
Whelan JT; Kellogg A; Shewchuk BM; Hewan-Lowe K; Bertrand FE
J Cell Biochem; 2009 Aug; 107(5):992-1001. PubMed ID: 19479935
[TBL] [Abstract][Full Text] [Related]
6. Activation of hepatocyte growth factor/MET signaling initiates oncogenic transformation and enhances tumor aggressiveness in the murine prostate.
Mi J; Hooker E; Balog S; Zeng H; Johnson DT; He Y; Yu EJ; Wu H; Le V; Lee DH; Aldahl J; Gonzalgo ML; Sun Z
J Biol Chem; 2018 Dec; 293(52):20123-20136. PubMed ID: 30401749
[TBL] [Abstract][Full Text] [Related]
7. Activation of nuclear PTEN by inhibition of Notch signaling induces G2/M cell cycle arrest in gastric cancer.
Kim SJ; Lee HW; Baek JH; Cho YH; Kang HG; Jeong JS; Song J; Park HS; Chun KH
Oncogene; 2016 Jan; 35(2):251-60. PubMed ID: 25823029
[TBL] [Abstract][Full Text] [Related]
8. Tumor-suppressive activity of Lunatic Fringe in prostate through differential modulation of Notch receptor activation.
Zhang S; Chung WC; Wu G; Egan SE; Xu K
Neoplasia; 2014 Feb; 16(2):158-67. PubMed ID: 24709423
[TBL] [Abstract][Full Text] [Related]
9. Klf5 deletion promotes Pten deletion-initiated luminal-type mouse prostate tumors through multiple oncogenic signaling pathways.
Xing C; Ci X; Sun X; Fu X; Zhang Z; Dong EN; Hao ZZ; Dong JT
Neoplasia; 2014 Nov; 16(11):883-99. PubMed ID: 25425963
[TBL] [Abstract][Full Text] [Related]
10. Notch signaling in prostate cancer: refining a therapeutic opportunity.
Su Q; Xin L
Histol Histopathol; 2016 Feb; 31(2):149-57. PubMed ID: 26521657
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation.
Wang XD; Leow CC; Zha J; Tang Z; Modrusan Z; Radtke F; Aguet M; de Sauvage FJ; Gao WQ
Dev Biol; 2006 Feb; 290(1):66-80. PubMed ID: 16360140
[TBL] [Abstract][Full Text] [Related]
12. Serum cholesterol levels and tumor growth in a PTEN-null transgenic mouse model of prostate cancer.
Allott EH; Masko EM; Freedland AR; Macias E; Pelton K; Solomon KR; Mostaghel EA; Thomas GV; Pizzo SV; Freeman MR; Freedland SJ
Prostate Cancer Prostatic Dis; 2018 Jun; 21(2):196-203. PubMed ID: 29795142
[TBL] [Abstract][Full Text] [Related]
13. HES6 promotes prostate cancer aggressiveness independently of Notch signalling.
Carvalho FL; Marchionni L; Gupta A; Kummangal BA; Schaeffer EM; Ross AE; Berman DM
J Cell Mol Med; 2015 Jul; 19(7):1624-36. PubMed ID: 25864518
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of notch expression during murine prostate development and tumorigenesis.
Shou J; Ross S; Koeppen H; de Sauvage FJ; Gao WQ
Cancer Res; 2001 Oct; 61(19):7291-7. PubMed ID: 11585768
[TBL] [Abstract][Full Text] [Related]
15. NFATc1 promotes prostate tumorigenesis and overcomes PTEN loss-induced senescence.
Manda KR; Tripathi P; Hsi AC; Ning J; Ruzinova MB; Liapis H; Bailey M; Zhang H; Maher CA; Humphrey PA; Andriole GL; Ding L; You Z; Chen F
Oncogene; 2016 Jun; 35(25):3282-92. PubMed ID: 26477312
[TBL] [Abstract][Full Text] [Related]
16. Caveolin-1 promotes tumor progression in an autochthonous mouse model of prostate cancer: genetic ablation of Cav-1 delays advanced prostate tumor development in tramp mice.
Williams TM; Hassan GS; Li J; Cohen AW; Medina F; Frank PG; Pestell RG; Di Vizio D; Loda M; Lisanti MP
J Biol Chem; 2005 Jul; 280(26):25134-45. PubMed ID: 15802273
[TBL] [Abstract][Full Text] [Related]
17. Liver X receptors constrain tumor development and metastasis dissemination in PTEN-deficient prostate cancer.
Alioui A; Dufour J; Leoni V; Loregger A; Moeton M; Iuliano L; Zerbinati C; Septier A; Val P; Fouache A; Russo V; Volle DH; Lobaccaro JA; Zelcer N; Baron S
Nat Commun; 2017 Sep; 8(1):445. PubMed ID: 28874658
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Notch pathway arrests PTEN-deficient advanced prostate cancer by triggering p27-driven cellular senescence.
Revandkar A; Perciato ML; Toso A; Alajati A; Chen J; Gerber H; Dimitrov M; Rinaldi A; Delaleu N; Pasquini E; D'Antuono R; Pinton S; Losa M; Gnetti L; Arribas A; Fraering P; Bertoni F; Nepveu A; Alimonti A
Nat Commun; 2016 Dec; 7():13719. PubMed ID: 27941799
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-153 promotes cell proliferation via downregulation of the PTEN tumor suppressor gene in human prostate cancer.
Wu Z; He B; He J; Mao X
Prostate; 2013 May; 73(6):596-604. PubMed ID: 23060044
[TBL] [Abstract][Full Text] [Related]
20. An in vitro system to characterize prostate cancer progression identified signaling required for self-renewal.
Salah M; Nishimoto Y; Kohno S; Kondoh A; Kitajima S; Muranaka H; Nishiuchi T; Ibrahim A; Yoshida A; Takahashi C
Mol Carcinog; 2016 Dec; 55(12):1974-1989. PubMed ID: 26621780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
